• Home
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Technology
  • Product Pipeline
    • Cancer Tests
    • Pharma Support
  • News & Information
    • News
    • Publications
  • Contact Us
  • Home
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Technology
  • Product Pipeline
    • Cancer Tests
    • Pharma Support
  • News & Information
    • News
    • Publications
  • Contact Us

Microsatellite Genotyping in Lung Cancer

  • Posted by ventac
  • On August 8, 2017
  • 0 Comments
  • genomics, medicine

Orbit Genomics Co-Founder and CSO, Dr. Harold “Skip” Garner, is the senior author on a paper appearing in Oncogene (31 July 2017) entitled “High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification” and can be viewed at http://rdcu.be/uCMU.

Early detection and screening for lung cancer can help overcome the high incidence and poor survival rates of this deadly disease. While low dose spiral CT is the only currently recommended screening test for lung cancer, it is not without numerous shortcomings. In this study, the authors demonstrated that  variations in DNA microsatellites (MST) play a role in the genetics of the mechanism of lung carcinogenesis. A set of (13) MST loci were identified and validated for lung cancer risk to be used in a high sensitivity, high specificity risk classifier blood test.  Orbit Genomics will utilize this MST platform technology to aid in early lung cancer detection by creating clinically actionable diagnostics for lung cancer.  High risk patients will be identified for enhanced monitoring or preventative measures.

 

0 Comments

Leave Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts
  • Orbit Genomics strengthens its Board of Directors with the appointment of Morten Søgaard, PhD
  • Orbit Genomics is thrilled to be part of 18 companies selected from more than 850 applicants for to Plug and Play’s Health Batch 9
  • Orbit Genomics is presenting at the Rocky Mountain Life Science Investor and Partnering Conference on Sep 5
  • Orbit Genomics is recognized by MedTech Innovator as one of the 50 best-in-class startups in the medtech industry.
  • CSO, Skip Garner, in the News
Recent Comments
    Archives
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • August 2017
    • February 2017

    Science in Genomic Medicine

    Previous thumb

    CSO, Skip Garner, in the News

    Next thumb
    Scroll
    Quick Links
    • Home
    • About Us
    • Contact
    Information
    • Science & Technology
    • Product Pipeline
    • News & Information
    Contact

    menu_dot Phone:
         720-515-0395

    menu_dot Email:
         info@orbitgenomics.com

         Social Media

         Facebook  Twitter  Linkedin

    Ventac Partners
    ventac-partners

    @2017 OrbitGenetics.com - Powered by wprezz.com

    WordPress Web Design by Simplio_Web_Studio_logo